Answers are grounded in this paper and cite their sources.
Our data provide the first evidence that LN18 and LN 229 human GBM cells express leptin mRNA and might produce biologically active leptin, which can stimulate tube formation and enhance proliferation of endothelial cells. Furthermore, we demonstrate for the first time that a peptide ObR antagonist inhibits proangiogenic and growth effects of leptin on endothelial cells, and that the pharmacological potential of this compound might be combined with drugs targeting the VEGF pathway.
No takes yet. Share an insight, caveat, or question.
Ferla et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: